ClinicalTrialsFinder

Anti-3-hydroxy-3-methylglutaryl-CoA Reductase (HMGCR) Immune-Mediated Necrotizing Myopathy Clinical Trials in Seattle, Washington

1 recruitingSeattle, Washington

Showing 1–1 of 1 trials

Recruiting
Phase 2

The MIGHT Trial - An Exploratory Clinical Trial of IVIG in Anti-HMGCR Immune Mediated Necrotizing Myopathy

Anti-3-hydroxy-3-methylglutaryl-CoA Reductase (HMGCR) Immune-Mediated Necrotizing Myopathy
University of Alabama at Birmingham12 enrolled5 locationsNCT06599697